Interim results of an ongoing phase 1/2a study of HPN328, a tri-specific, half-life extended, DLL3-targeting, T-cell engager, in patients with small cell lung cancer and other neuroendocrine cancers.
已取消
10
由 行止 发布于 2025/6/6 0:30:46
文献类型：期刊论文
补充材料：只需要正文
管理员驳回:Free Access, https://ascopubs.org/doi/10.1200/JCO.2022.40.16_suppl.8566
补充材料：只需要正文
管理员驳回:Free Access, https://ascopubs.org/doi/10.1200/JCO.2022.40.16_suppl.8566
其它数据库
应助信息
2025-06-06
Book学术机器人
2025/6/6 0:30:46
未找到该文献，机器人已退出，请等待人工下载
2025/6/6 0:30:46
Book学术AI机器人收到请求，开始寻找文献
2025/6/6 0:30:46
已向机器人发送请求
2025-06-06
行止
发布求助
上一个求助:
其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary
下一个求助:
American Society of Clinical Oncology (ASCO)Interim results from a phase 1/2 study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T-cell engager, in patients (pts) with neuroendocrine prostate cancer (NEPC) and other neuroendocrine neoplasms (NEN).
其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary
下一个求助:American Society of Clinical Oncology (ASCO)Interim results from a phase 1/2 study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T-cell engager, in patients (pts) with neuroendocrine prostate cancer (NEPC) and other neuroendocrine neoplasms (NEN).
京公网安备 11010802042870号
